Compounds > 2-n-butyl-3-(dimethylamino)-5,6-methylenedioxyindene
Page last updated: 2024-09-03

2-n-butyl-3-(dimethylamino)-5,6-methylenedioxyindene and Coronary Disease

2-n-butyl-3-(dimethylamino)-5,6-methylenedioxyindene has been researched along with Coronary Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lucchesi, BR; Lynch, JJ; Rahwan, RG1

Other Studies

1 other study(ies) available for 2-n-butyl-3-(dimethylamino)-5,6-methylenedioxyindene and Coronary Disease

ArticleYear
Antifibrillatory actions of bepridil and butyl-MDI, two intracellular calcium antagonists.
    European journal of pharmacology, 1985, Apr-23, Volume: 111, Issue:1

    Topics: Animals; Anti-Arrhythmia Agents; Bepridil; Calcium; Calcium Channel Blockers; Coronary Circulation; Coronary Disease; Dogs; Electrocardiography; Indenes; Male; Pyrrolidines

1985